Literature DB >> 3266359

Quantitative analysis of precursors frequency of rheumatoid factor (RF) producing human B cells.

T L Vischer1, C F Werner-Favre, L Wen, R H Zubler.   

Abstract

Recently, a new culture system has been devised which leads to activation, proliferation and differentiation into antibody secreting cells of at least 90% of human peripheral blood B-lymphocytes. The system uses mutant EL-4 thymoma cells of mouse origin for B cell activation and T cell/macrophage supernatant as source of cytokines (L. Wen et al., Eur. J. Immunol. 17, 887, 1987). By an ELISA system with Fc fragments as antigen and the F(ab)2 fragment of antibodies against human IgM labelled with alkaline phosphatase, we analysed the frequencies of B cells producing IgM-RFs. The mean frequency of IgM-RF producing cells in normal controls was 1/3100 (s.d. = 0.2 log; n = 5) of circulating B cells. In 2 patients with seropositive rheumatoid arthritis (RA) the frequencies were higher (1/492; 1/262), but in 2 other seropositive patients a normal (1/5540) or even a decreased (1/20000) frequency was observed. The possible relation between circulating and synovial RF producing B cells is currently being investigated.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3266359     DOI: 10.3109/03009748809096752

Source DB:  PubMed          Journal:  Scand J Rheumatol Suppl        ISSN: 0301-3847


  4 in total

1.  Determination of the frequency of HLA antibody secreting B-lymphocytes in alloantigen sensitized individuals.

Authors:  A Mulder; M J Kardol; J Kamp; C Uit Het Broek; G M Schreuder; I I Doxiadis; F H Claas
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

2.  Monospecific but not polyreactive human hybridoma rheumatoid factors exhibit preferential binding specificities for IgG3 and IgG4.

Authors:  M M Newkirk; J Rauch
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

3.  The B cell repertoire of patients with rheumatoid arthritis. Frequencies and specificities of peripheral blood B cells reacting with human IgG, human collagens, a mycobacterial heat shock protein and other antigens.

Authors:  U Rudolphi; A Hohlbaum; B Lang; H H Peter; I Melchers
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

Review 4.  Advances in rheumatology: new targeted therapeutics.

Authors:  Paul P Tak; Joachim R Kalden
Journal:  Arthritis Res Ther       Date:  2011-05-25       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.